BRIEF-Cell Therapeutics's OPAXIOTM receives orphan drug designation

Published 9:41 AM ET Sun, 11 Nov 2012

Oct 2 (Reuters) - Cell Therapeutics Inc :

* OPAXIOTM receives orphan drug designation for malignant brain cancer from FDA

((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))

((For more news, please click here ))

Related Securities

Symbol	Price		Change	%Change
CTIC		---